Skip to content

Circulating markers in fluid samples of malignant tumors to assist in the diagnosis of tumor progression

Circulating markers in fluid samples of malignant tumors to assist in the diagnosis of tumor progression

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065557
Enrollment
Unknown
Registered
2022-11-08
Start date
2022-11-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

Case group:N/A
Control group:N/A

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Consent form signed by the legally authorized client of the patient; 2. Patients of both genders and ages; 3. Patients who are hospitalized in our hospital due to malignant tumors and whose clinicians judge that blood or body fluid testing is necessary to provide evidence for clinical disease diagnosis, evaluation and treatment;

Exclusion criteria

Exclusion criteria: 1. The subject expressly refuses to participate in the study; 2. Subjects deemed unsuitable for this study by the investigator;

Design outcomes

Primary

MeasureTime frame
exosome;

Countries

China

Contacts

Public ContactWang Xu

The First Affiliated Hospital of Soochow University

wangxu119a@163.com+86 18896570603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026